Kevin S. Clive

发表

Folate receptor α: A storied past and promising future in immunotherapy

E. Mittendorf, G. Peoples, G. Clifton, 2011, Human vaccines.

Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?

E. Mittendorf, G. Peoples, G. Clifton, 2010, Expert review of vaccines.

Clinical trial results of the HER‐2/neu (E75) vaccine to prevent breast cancer recurrence in high‐risk patients

A. Stojadinovic, E. Mittendorf, G. Peoples, 2012, Cancer.

The GP2 peptide: A HER2/neu‐based breast cancer vaccine

E. Mittendorf, G. Peoples, G. Clifton, 2012, Journal of surgical oncology.

AE37: a novel T-cell-eliciting vaccine for breast cancer

E. Mittendorf, G. Peoples, S. Perez, 2011, Expert opinion on biological therapy.

Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines

E. Mittendorf, G. Peoples, G. Clifton, 2011, Expert review of vaccines.

Standardized pretreatment breast MRI—accuracy and influence on mastectomy decisions

G. Peoples, Kevin P. Banks, Aaron D. Kirkpatrick, 2011, Journal of surgical oncology.

Current US military operations and implications for military surgical training.

Lorne H Blackbourne, Christopher E White, Alec C Beekley, 2010, Journal of the American College of Surgeons.

Comparison of Outcomes of antibiotic Drugs and Appendectomy (CODA) trial: a protocol for the pragmatic randomised study of appendicitis treatment

P. Heagerty, D. Flum, D. Lavallee, 2017, BMJ Open.

Use of lanreotide for the treatment of gastrointestinal fistulae.

S. Cohn, Mark O. Hardin, Kevin S. Clive, 2011, Annals of surgery.

Colorectal Prostate Skin Cancer Screening Among Hispanic White Non-Hispanic Men 2000–2005

J. Potter, S. Steele, A. Stojadinovic, 2011 .